Mandate

Vinge has advised Priveq Investment in connection with the investment in ROL

Today ROL offers workspace solutions including software and ergonomically optimized office furniture and store concept solutions. ROL’s offering is sold globally both through ROL’s own sales organization and distributors. In 2020, ROL had a turnover of approximately SEK 1.6 billion and 890 employees in ten different countries.

The Hjelm family has partnered with Priveq Investment as a new minority owner to support the company in its accelerated growth strategy. The Hjelm family will continue as majority owners in ROL, with Arne Karlsson continuing as the Chairman of the Board.

Vinge’s team consisted of Jonas Johansson, Karl Klackenberg and Jesper Lindvall (M&A), together with Kristoffer Larson (Real Estate), Johan Cederblad and Lina Österberg (Environment), Jolene Reimerson and Mathilda Persson (IT, Agreements and GDPR), Sofia Bergenstråhle (IP), Karl-Gustaw Tobola (Financing), Ebba Svenburg (Employment), Carl Bruneheim and Viktoria Owetz Leyva (VDR).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025